Sign Up to like & get
recommendations!
1
Published in 2023 at "Journal of Obstetrics and Gynaecology Research"
DOI: 10.1111/jog.15644
Abstract: Apatinib is an effective treatment for patients with gynecological cancers. This study aimed to further explore the efficacy and safety of apatinib plus chemotherapy in patients with recurrent platinum‐resistant ovarian cancer (PROC).
read more here.
Keywords:
efficacy safety;
doxorubicin paclitaxel;
safety apatinib;
liposomal doxorubicin ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e15003
Abstract: e15003Background: Colorectal cancer is the third most frequent cancer and the fourth most frequent cause of cancer-related death worldwide.25% of patients with colorectal cancer have metastatic dis...
read more here.
Keywords:
safety apatinib;
apatinib patients;
efficacy safety;
colorectal cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e16006
Abstract: e16006Background: Antiangiogenic therapy in combination with chemotherapy has shown improved clinical benefit in advanced cancer. In third-line therapy, apatinib (a TKI against VEGFR-2) has shown g...
read more here.
Keywords:
safety apatinib;
clinical efficacy;
efficacy safety;
line ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "OncoTargets and therapy"
DOI: 10.2147/ott.s210748
Abstract: OncoTargets and Therapy is an international, peer-reviewed, open access journal focusing on the pathological basis of all cancers, potential targets for therapy and treatment protocols employed to improve the management of cancer patients. The journal…
read more here.
Keywords:
efficacy safety;
treatment gastric;
treatment;
cancer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.894016
Abstract: Background and Purpose: Apatinib is a novel antiangiogenic agent that can target vascular endothelial cell growth factor 2. The aim of our study was to evaluate the efficacy and safety of apatinib mesylate in the…
read more here.
Keywords:
apatinib;
hepatocellular carcinoma;
advanced hepatocellular;
efficacy safety ... See more keywords